Moreover, immune cytokine IL‐23 (anti‐IL‐23) and the JAK3 inhibitor could protect from cerebral ischemia–reperfusion injury by targeting the immune‐specific JAK2‐STAT3 in the JAK/STAT pathway because they decreased infarct volume more effectively. Here, JAK3 is linked to brain ischemia.